Evidence map›Paper›PMID 36358635›Full record

ArticleCancers2022

Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology.

Marcella Barbarino, Maria Bottaro, Laura Spagnoletti, Maria Margherita de Santi, Raffaella Guazzo, Chiara Defraia, Cosimo Custoza, Gabriella Serio, Francesco Iannelli, Matilde Pesetti and 6 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marcella BarbarinoDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.ORCID 0000-0001-9869-9814
Maria BottaroDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.ORCID 0000-0001-6951-0613
Laura SpagnolettiDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.
Maria Margherita de SantiDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.
Raffaella GuazzoDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.
Chiara DefraiaDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.
Cosimo CustozaDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.
Gabriella SerioDepartment of Emergency and Organ Transplantation-DETO, University of Bari, G. Cesare 1 Sq., 70121 Bari, Italy.ORCID 0000-0001-9021-4560
Francesco IannelliDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.ORCID 0000-0001-5064-1496
Matilde PesettiDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.
Raffaele AielloToma Institute Srl, Via Cesare Rosaroll 24, 80139 Napoli, Italy.
Diletta RosatiDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.ORCID 0000-0002-0449-2546
Edoardo ZanfriniDepartment of Medicine, Surgery and Neurosciences, Siena University Hospital, 53100 Siena, Italy.
Luca LuzziDepartment of Medicine, Surgery and Neurosciences, Siena University Hospital, 53100 Siena, Italy.
Cristiana BellanDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.ORCID 0000-0001-6119-9007
Antonio GiordanoDepartment of Medical Biotechnologies, Siena University, 53100 Siena, Italy.ORCID 0000-0002-5959-016X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary cilium (PC) is a sensory organelle present on the cell surface, modulating the activity of many pathways. Dysfunctions in the PC lead to different pathologic conditions including cancer. Hedgehog signaling (Hh) is regulated by PC and the loss of its control has been observed in many cancers, including mesothelioma. Malignant pleural mesothelioma (MPM) is a fatal cancer of the pleural membranes with poor therapeutic options. Recently, overexpression of the Hh transcriptional activator GL1 has been demonstrated to be associated with poor overall survival (OS) in MPM. However, unlike other cancers, the response to G-protein-coupled receptor smoothened (SMO)/Hh inhibitors is poor, mainly attributable to the lack of markers for patient stratification. For all these reasons, and in particular for the role of PC in the regulation of Hh, we investigated for the first time the status of PC in MPM tissues, demonstrating intra- and inter-heterogeneity in its expression. We also correlated the presence of PC with the activation of the Hh pathway, providing uncovered evidence of a PC-independent regulation of the Hh signaling in MPM. Our study contributes to the understanding MPM heterogeneity, thus helping to identify patients who might benefit from Hh inhibitors.

Indexed as

GLI1hedgehog signalingmesotheliomapleuralprimary cilium

Identifiers

PMID36358635
PMCPMC9654223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.